This inventor holds 3 USPTO granted patents. Top assignees: Roussel Uclaf, Roussel-Ulcaf. Active years: 1989-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-1991
Title: Dankwart C Fenske: Innovator in Anti-Inflammatory Compounds
Introduction
Dankwart C Fenske is a notable inventor based in Weybridge, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-inflammatory compounds. With a total of 3 patents to his name, Fenske's work has had a meaningful impact on pharmaceutical research.
Latest Patents
Fenske's latest patents include innovative compounds such as Imidazolo [1,2-a]pyrimidines, which are recognized for their anti-inflammatory activity. This patent describes a compound selected from a specific formula and its non-toxic, pharmaceutically acceptable acid addition salts. Another significant patent focuses on anti-inflammatory imidazole compounds, detailing a compound selected from a defined group with similar non-toxic properties.
Career Highlights
Throughout his career, Fenske has worked with reputable companies, including Roussel Uclaf. His experience in the pharmaceutical industry has allowed him to develop and patent compounds that address critical health issues.
Collaborations
Fenske has collaborated with notable coworkers such as Elizabeth A Kuo and Wilfred R Tully, contributing to the advancement of research in his field.
Conclusion
Dankwart C Fenske's contributions to the development of anti-inflammatory compounds highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to advancing pharmaceutical science and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile